VSV-ZEBOV Geneva Vaccine Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

January 31, 2016

Conditions
Ebolavirus Disease
Interventions
BIOLOGICAL

VSV-ZEBOV

See arm/group descriptions.

Trial Locations (1)

1211

University Hospitals of Geneva, Geneva

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

Wellcome Trust

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Philipps University Marburg

OTHER

collaborator

Albert Schweitzer Hospital

OTHER

collaborator

Institute of Tropical Medicine, University of Tuebingen

OTHER

collaborator

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

lead

University Hospital, Geneva

OTHER

NCT02287480 - VSV-ZEBOV Geneva Vaccine Trial | Biotech Hunter | Biotech Hunter